Real-time enrollment status for this gaucher disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:31 PM UTC
| NCT Number | NCT05487599 |
| Recruiting Status | Recruiting |
| Condition | Gaucher Disease |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Prevail Therapeutics |
| Last Updated on CT.gov | July 13, 2026 (4 days ago) |
As of July 17, 2026: Clinical trial NCT05487599 is currently recruiting participants. This phase1 study for gaucher disease is actively seeking new participants at 4 locations across the United States. The study is sponsored by Prevail Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05487599 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05487599 was last updated 4 days ago (July 13, 2026). HelloStudys verifies this status automatically.